← All medicines

Metabolic medicines

Tesamorelin injection

Independent educational summary · Sources checked November 20, 2026

A growth hormone-releasing factor analog used to reduce excess abdominal fat in selected adults with HIV-associated lipodystrophy; it is not a general weight-loss medicine.

Profile scope: Tesamorelin injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Swelling, joint or muscle pain, tingling and injection-site reactions may occur.

Serious risks and warning signs

High blood sugar, elevated IGF-1, fluid retention and severe allergy require monitoring. Active malignancy and pregnancy affect suitability. Marked thirst, significant swelling, breathing difficulty or facial swelling needs prompt advice.

A question for your healthcare team

How will glucose, IGF-1 and response be followed, and does my cancer or pituitary history affect eligibility?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.